|
|
(One intermediate revision by one other user not shown) |
Line 1: |
Line 1: |
| {{drugbox
| | #REDIRECT [[Quinapril#Pharmacology]] |
| | IUPAC_name = (3''S'')-2-[(2''S'')-2-<nowiki>[[</nowiki>(1''S'')-1-ethoxycarbonyl-3-phenyl-<br>propyl]amino]propanoyl]-3,4-dihydro-1''H''-isoquinoline-<br>3-carboxylic acid
| |
| | image = Quinapril_svg.png
| |
| | width = 180px
| |
| | CAS_number = 85441-61-8
| |
| | ATC_prefix = C09
| |
| | ATC_suffix = AA06
| |
| | PubChem = 54892
| |
| | DrugBank = APRD00523
| |
| | C = 25 | H = 30 | N = 2 | O = 5
| |
| | molecular_weight = 438.516 g/mol
| |
| | bioavailability =
| |
| | protein_bound = 97%
| |
| | metabolism =
| |
| | elimination_half-life = 2 hours
| |
| | pregnancy_category = D
| |
| | legal_status = Rx-only
| |
| | routes_of_administration =
| |
| }}
| |
| {{SI}}
| |
| {{CMG}}
| |
| | |
| {{Editor Join}}
| |
| | |
| ==[[Quinapril (patient information)|For patient information, click here]]==
| |
| | |
| '''Quinapril''' (marketed under the brand name '''Accupril''' by [[Pfizer]]) is an [[angiotensin-converting enzyme]] [[enzyme inhibitor|inhibitor]] ([[ACE inhibitor]]) used in the treatment of [[hypertension]] and [[congestive heart failure]].
| |
| | |
| ==Pharmacology==
| |
| Quinapril is a [[prodrug]]. It is converted to its active metabolite, quinaprilat, in the liver.
| |
| | |
| ==Mechanism of action==
| |
| {{main|ACE inhibitor}}
| |
| {{see also|Angiotensin|renin-angiotensin system}}
| |
| | |
| Quinapril inhibits [[angiotensin converting enzyme]], an enzyme which [[catalysis|catalyses]] the formation of [[angiotensin]] [[Angiotensin#Angiotensin II|II]] from its precursor, [[Angiotensin#Angiotensin I|angiotensin I]]. Angiotensin II is a powerful [[vasoconstrictor]] and increases blood pressure through a variety of mechanisms. Due to reduced angiotensin production, plasma concentrations of [[aldosterone]] are also reduced, resulting in increased excretion of [[sodium]] in the urine and increased concentrations of [[potassium]] in the blood.
| |
| | |
| ==Indications==
| |
| Quinapril is indicated for the treatment of high blood pressure ([[hypertension]]) and as adjunctive therapy in the management of [[heart failure]]. It may be used for the treatment of hypertension by itself or in combination with [[thiazide diuretic]]s, and with diuretics and [[digoxin]] for heart failure.
| |
| | |
| ==Contraindications==
| |
| <li>Pregnancy
| |
| <li>Impaired renal and liver function
| |
| <li>Patients with a history of angioedema related to previous treatment with an ACE inhibitor.
| |
| <li>Hypersensitive to Quinapril
| |
| | |
| ==Side effects==
| |
| [[Adverse drug reaction|Side effect]]s of quinapril include dizziness, cough, vomiting, upset stomach and [[fatigue (medical)|fatigue]].
| |
| | |
| ==External links==
| |
| *[http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a692026.html Quinapril FAQ]
| |
| *[http://www.accupril.com Accupril Site]
| |
| | |
| | |
| {{ACE inhibitors}}
| |
| | |
| [[Category:ACE inhibitors]]
| |
| [[Category:Prodrugs]]
| |
| [[Category:Drugs]]
| |
| | |
| [[fr:Quinapril]]
| |
| [[hu:Quinapril]]
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |